Stanford University School of Medicine, Division of Hematology — Palo Alto, California

Stanford University School of Medicine, Division of Hematology is a clinical research site located in Palo Alto, California, United States 94025.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford University School of Medicine, Division of Hematology has participated in 1 clinical trials.

Therapeutic areas: Primary Myelofibrosis, Fibrosis, Bone Marrow.

Sponsors: Infinity Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford University School of Medicine, Division of Hematology?

Stanford University School of Medicine, Division of Hematology has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford University School of Medicine, Division of Hematology conducted?

Stanford University School of Medicine, Division of Hematology has 1 clinical trials on record. Their work covers Primary Myelofibrosis, Fibrosis, Bone Marrow.

Is Stanford University School of Medicine, Division of Hematology accredited by Crixeo Health?

Stanford University School of Medicine, Division of Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford University School of Medicine, Division of Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.